A historical perspective on ACE2 in the COVID-19 era

被引：37
作者：
Bhalla, Vivek [1 ,2 ,3 ]
Blish, Catherine A. [3 ,4 ,5 ]
South, Andrew M. [6 ,7 ,8 ]
机构：
[1] Stanford Univ, Sch Med, Stanford Hypertens Ctr, Stanford, CA 94305 USA
[2] Stanford Univ, Sch Med, Div Nephrol, Stanford, CA 94305 USA
[3] Stanford Univ, Sch Med, Dept Med, Stanford, CA 94305 USA
[4] Stanford Univ, Sch Med, Div Infect Dis & Geog Med, Stanford, CA 94305 USA
[5] Chan Zuckerberg Biohub, San Francisco, CA USA
[6] Wake Forest Sch Med, Brenner Childrens Hosp, Dept Pediat, Sect Nephrol, Winston Salem, NC 27101 USA
[7] Wake Forest Sch Med, Dept Surg Hypertens & Vasc Res, Winston Salem, NC 27101 USA
[8] Wake Forest Sch Med, Dept Epidemiol & Prevent, Div Publ Hlth Sci, Winston Salem, NC 27101 USA
来源：
JOURNAL OF HUMAN HYPERTENSION | 2021年 / 35卷 / 10期
关键词：
ANGIOTENSIN-CONVERTING ENZYME; AMINO ACID COMPOSITION; RECEPTOR; INHIBITORS; CORONAVIRUS; EXPRESSION; IDENTIFICATION; ANTAGONIST; CAPTOPRIL; BLOCKADE;
D O I：
10.1038/s41371-020-00459-3
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
引用
收藏
页码：935 / 939
页数：5
相关论文
共 41 条
  • [11] Oxidative stress is a critical mediator of the angiotensin II signal in human neutrophils:: involvement of mitogen-activated protein kinase, calcineurin, and the transcription factor NF-κB
    El Bekay, R
    Alvarez, M
    Monteseirín, J
    Alba, G
    Chacón, P
    Vega, A
    Martín-Nieto, J
    Jiménez, J
    Pintado, E
    Bedoya, FJ
    Sobrino, F
    [J]. BLOOD, 2003, 102 (02) : 662 - 671
  • [12] AMINO-ACID SEQUENCE IN A HYPERTENSIN
    ELLIOTT, DF
    PEART, WS
    [J]. NATURE, 1956, 177 (4507) : 527 - 528
  • [13] Opportunities for Targeting the Angiotensin-Converting Enzyme 2/Angiotensin-(1-7)/Mas Receptor Pathway in Hypertension
    Fraga-Silva, Rodrigo Araujo
    Ferreira, Anderson Jose
    Souza dos Santos, Robson Augusto
    [J]. CURRENT HYPERTENSION REPORTS, 2013, 15 (01) : 31 - 38
  • [14] NADPH oxidases and angiotensin II receptor signaling
    Garrido, Abel Martin
    Griendling, Kathy K.
    [J]. MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2009, 302 (02) : 148 - 158
  • [15] STUDIES OF PATHOGENESIS OF HUMAN HYPERTENSION - ADRENAL CORTEX AND RENAL PRESSOR MECHANISM
    GENEST, J
    BOUCHER, R
    BIRON, P
    NOWACZYNSKI, W
    CHRETIEN, M
    KOIW, E
    [J]. ANNALS OF INTERNAL MEDICINE, 1961, 55 (01) : 12 - +
  • [16] Computational Design of ACE2-Based Peptide Inhibitors of SARS-CoV-2
    Han, Yanxiao
    Kral, Petr
    [J]. ACS NANO, 2020, 14 (04) : 5143 - 5147
  • [17] Pharmacokinetics and Pharmacodynamics of Recombinant Human Angiotensin-Converting Enzyme 2 in Healthy Human Subjects
    Haschke, Manuel
    Schuster, Manfred
    Poglitsch, Marko
    Loibner, Hans
    Salzberg, Marc
    Bruggisser, Marcel
    Penninger, Joseph
    Kraehenbuehl, Stephan
    [J]. CLINICAL PHARMACOKINETICS, 2013, 52 (09) : 783 - 792
  • [18] Angiotensin converting enzyme inhibitors and risk of lung cancer: population based cohort study
    Hicks, Blanaid M.
    Filion, Kristian B.
    Yin, Hui
    Sakr, Lama
    Udell, Jacob A.
    Azoulay, Laurent
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2018, 363
  • [19] A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury
    Kuba, K
    Imai, Y
    Rao, SA
    Gao, H
    Guo, F
    Guan, B
    Huan, Y
    Yang, P
    Zhang, YL
    Deng, W
    Bao, LL
    Zhang, BL
    Liu, G
    Wang, Z
    Chappell, M
    Liu, YX
    Zheng, DX
    Leibbrandt, A
    Wada, T
    Slutsky, AS
    Liu, DP
    Qin, CA
    Jiang, CY
    Penninger, JM
    [J]. NATURE MEDICINE, 2005, 11 (08) : 875 - 879
  • [20] THE AMINO ACID COMPOSITION OF HYPERTENSIN-II AND ITS BIOCHEMICAL RELATIONSHIP TO HYPERTENSIN-I
    LENTZ, KE
    SKEGGS, LT
    WOODS, KR
    KAHN, JR
    SHUMWAY, NP
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1956, 104 (02) : 183 - 191
12345